Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medical Economics of Urinary PCA3 Test for Prostate Cancer Diagnosis

NCT01632930 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT01632930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01632930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medical Economics of Urinary PCA3 Test for Prostate Cancer Diagnosis
Lead sponsor
Hospices Civils de Lyon
Phase
Not applicable
Overall status
Completed
Start date
July 2, 2012
Completion date
April 26, 2021
Enrollment
962 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

patients scheduled for prostate biopsy because of increased serum psa and/or abnormal digital rectal examination